رجوع
4
مُدرج أيضًا باسم
SHPMY
OTC
نطاق اليوم
KWD 1.46
KWD 1.46
نطاق 52 أسبوعًا
KWD 1.46
KWD 15.70
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 1.49
/
KWD 1.53
الإغلاق السابق
KWD 1.46
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 1.9 | 0.3 |
| P/B | 0.1 | 2.9 |
| ROE % | 6.5 | 3.7 |
| Net Margin % | 1.7 | 3.8 |
| Rev Growth 5Y % | 9.4 | 10.0 |
| D/E | 0.7 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 1.497
KWD 1.432 – KWD 1.594
|
320 B | 1 |
| FY2026 |
KWD 1.363
KWD 1.304 – KWD 1.451
|
300 B | 1 |
النقاط الرئيسية
Revenue grew 9.44% annually over 5 years — modest growth
Earnings grew 20.82% over the past year
Generating 3.43B in free cash flow
P/E of 1.86 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.69%
Capital efficient — spends only 0.87% of revenue on capex
النمو
Revenue Growth (5Y)
9.44%
Revenue (1Y)5.75%
Earnings (1Y)20.82%
FCF Growth (3Y)29.02%
الجودة
Return on Equity
6.49%
ROIC5.11%
Net Margin1.65%
Op. Margin2.96%
الأمان
Debt / Equity
0.67
Current Ratio1.36
Interest Coverage5.01
التقييم
P/E Ratio
1.86
P/B Ratio0.12
EV/EBITDA2.52
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.75% | Revenue Growth (3Y) | 8.93% |
| Earnings Growth (1Y) | 20.82% | Earnings Growth (3Y) | -9.97% |
| Revenue Growth (5Y) | 9.44% | Earnings Growth (5Y) | 0.31% |
| Profitability | |||
| Revenue (TTM) | 275.25B | Net Income (TTM) | 4.55B |
| ROE | 6.49% | ROA | 2.06% |
| Gross Margin | 11.13% | Operating Margin | 2.96% |
| Net Margin | 1.65% | Free Cash Flow (TTM) | 3.43B |
| ROIC | 5.11% | FCF Growth (3Y) | 29.02% |
| Safety | |||
| Debt / Equity | 0.67 | Current Ratio | 1.36 |
| Interest Coverage | 5.01 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 1.86 | P/B Ratio | 0.12 |
| P/S Ratio | 0.03 | PEG Ratio | 4.73 |
| EV/EBITDA | 2.52 | Dividend Yield | 0.01% |
| Market Cap | 8.46B | Enterprise Value | 20.51B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 275.25B | 260.30B | 231.98B | 215.82B | 191.91B |
| Net Income | 4.55B | 3.77B | 5.62B | 5.09B | 4.50B |
| EPS (Diluted) | 1.23 | 1.02 | 1.61 | 1.79 | 1.58 |
| Gross Profit | 30.63B | 31.33B | 30.49B | 28.54B | 27.44B |
| Operating Income | 8.14B | 7.67B | 9.01B | 8.21B | 7.18B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 221.21B | 211.97B | 198.13B | 163.44B | 149.19B |
| Total Liabilities | 137.47B | 131.65B | 120.13B | 104.37B | 94.44B |
| Shareholders' Equity | 71.68B | 68.52B | 67.06B | 49.36B | 45.35B |
| Total Debt | 47.79B | 42.90B | 38.56B | 31.69B | 31.79B |
| Cash & Equivalents | 35.74B | 30.52B | 27.40B | 22.39B | 22.30B |
| Current Assets | 171.82B | 162.43B | 149.51B | 116.49B | 107.56B |
| Current Liabilities | 126.04B | 122.37B | 110.69B | 91.82B | 88.13B |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#607 of 618
النشاط الأخير
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026